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Abstract 
 
Thoracolumbar intervertebral disc protrusion (IVDP) is a disabling degenerative condition, typically 
affecting older, large breed dogs. To date, very few studies have investigated the clinical 
characteristics of IVDP, and hence there is little information available to facilitate clinical decision-
making and management of client expectations.  The aim of this retrospective case series was to 
compare the clinical presentation of dogs receiving medical or surgical treatment for thoracolumbar 
IVDP, and to assess the outcome following medical treatment. Significantly more medically treated 
dogs (n= 31) had concurrent disease at the time of presentation and had less severe spinal cord 
compression, while significantly more surgically treated dogs (n= 53) had neurological deficits and 
were non-ambulatory at presentation. Outcome data was available for 27 of 31 medically managed 
dogs; 11 (40.7%) initially improved with treatment, 7 (25.9%) remained stable, and 9 (33.3%) 
deteriorated. The median survival time for dogs receiving medical treatment was 330 days.  Of 18 
dogs that initially improved or stabilised, 10 showed a recurrence of clinical signs (55.6%).  
Therefore, the clinical presentation differed between treatment groups, with surgically managed 
dogs typically having a more severe clinical phenotype.  Medical management can provide a fair 
prognosis, however, recurrence of clinical signs is common.   
  
Two types of degenerative intervertebral disc disease have historically been recognized. Type 
I intervertebral disc disease, or intervertebral disc extrusion (IVDE), involves the herniation 
of degenerate and calcified nucleus pulposus material through all layers of the ruptured 
anulus fibrosus into the vertebral canal.  It is seen most commonly in chondrodystrophic dog 
breeds between 3 and 7 years old, and typically results in an acute onset of severe 
neurological deficits.1-4 Type II intervertebral disc disease, or intervertebral disc protrusion 
(IVDP), more commonly affects older, non-chondrodystrophic large breed dogs. In contrast 
to IVDE, pathological abnormalities are predominantly seen in the anulus fibrosus. Dorsal 
displacement of the nucleus pulposus through the weakened anulus causes the anulus fibrosus 
to protrude into the vertebral canal, leading to progressive spinal cord compression.  Affected 
dogs typically demonstrate a chronic onset of progressive, but relatively mild clinical signs, 
such as spinal hyperesthesia, ambulatory paresis and proprioceptive ataxia.2,3,5  The vast 
majority of studies have evaluated IVDE and hence this type of intervertebral disc disease is 
well characterized with outcomes after medical and surgical management extensively 
reported.6-11  However, very few studies have investigated the clinical characteristics of 
IVDP, and hence there is little information available to facilitate clinical decision-making and 
management of client expectations. As for IVDE, both medical and surgical treatment options 
exist for the management of thoracolumbar IVDP.4,12,13 While there is relatively little 
discussion regarding the preferred surgical technique for dogs with thoracolumbar IVDE, 
which are typically managed with a hemilaminectomy, several techniques have been 
suggested for IVDP. These include a hemilaminectomy with anulectomy, dorsal 
laminectomy, lateral corpectomy, partial lateral corpectomy, and a hemilaminectomy 
combined with vertebral stabilization.13-17  These suggested techniques are technically 
demanding and are complicated by the fact that affected dogs often present with multiple 
sites of spinal cord compression.4,17 Furthermore, there is a risk of severe neurological 
deterioration immediately after surgery due to the challenges of satisfactorily removing the 
protruded annulus without causing further spinal cord injury and the chronicity of the spinal 
cord compression with its associated pre-existing spinal cord pathology.4,18,19  
Given the challenges inherent in surgical treatment, the option of medical management 
should be considered for cases presenting with IVDP.  However, there is little known about 
the use of medical management for dogs with IVDP, also the factors that currently influence 
the decision on whether medical or surgical treatment is pursued. Therefore, the aims of this 
study were to compare the clinical presentation of dogs receiving medical or surgical 
treatment for thoracolumbar IVDP, and to assess the outcome following medical treatment.  
We hypothesized that medically treated dogs would show less severe clinical signs, with less 
severe spinal cord compression, compared to dogs treated surgically, and that medical 
management could result in a fair to good outcome.    
 
Materials and methods  
 
Digital medical records from 1st January 2006 to 30th April 2015 from the Royal Veterinary College 
Small Animal Referral Hospital were searched for the following terms: thoracolumbar intervertebral 
disc protrusion, thoracolumbar intervertebral disc herniation, and thoracolumbar intervertebral disc 
disease.  Dogs with complete medical records, compatible clinical signs and a diagnosis of 
thoracolumbar IVDP confirmed by diagnostic imaging and/or surgical findings were included in the 
study.  The diagnosis of IVDP was based on surgical confirmation of the type of IVDD, or 
published myelographic criteria4, or previously evaluated MRI criteria.20  Dogs were excluded if 
clinical records or imaging studies were incomplete or unavailable for review. The study was 
approved by the Royal Veterinary College Ethics and Welfare Committee (Protocol number URN 
20151344). 
 
Information retrieved from the medical records included signalment, duration, type and 
severity of clinical signs, treatment received before referral, general physical and neurologic 
examination findings, presence and type of neurologic deficits, presence and type of 
concurrent medical conditions and results of diagnostic tests including diagnostic imaging.  
Neurologic status was graded by the modified Frankel score which was defined as paraplegia 
with no deep nociception (grade 0), paraplegia with no superficial nociception (grade 1), 
paraplegia with nociception (grade 2), non-ambulatory paraparesis (grade 3), ambulatory 
paraparesis and ataxia (grade 4), spinal hyperesthesia only (grade 5), or no dysfunction.21 
Concurrent medical conditions were further categorized as orthopaedic or non-orthopaedic.  
For dogs that received medical treatment prior to referral, a static or deteriorated clinical 
status before initial evaluation at the Royal Veterinary College was considered as 
unsuccessful medical treatment before referral. 
 
Diagnosis of IVDP was made by evaluation of myelographic or MR images. Anesthetic 
protocols varied between dogs but typically included premedication with a combination of 
acepromazine maleate (0.01 mg/kg [0.0045 mg/lb], IV) and methadone (0.1 to 0.2 mg/kg 
[0.045 to 0.091 mg/ lb], IV), which was followed by anesthetic induction with propofol (4 to 
6 mg/kg [1.82 to 2.73 mg/lb], IV) and maintenance of anesthesia with isoflurane in oxygen. 
Myelography was performed in dogs following intrathecal injection of iohexola contrast 
medium (0.2 mL/kg [0.09 mL/lb] with a maximal dose of 10 mL) through the L5-6 
interspace. The complete vertebral column was imaged during myelography and radiographs 
were obtained in orthogonal and oblique views. For MRI, a 1.5 Tesla unit was used.b Dogs 
were placed in dorsal recumbency, and protocols included a minimum of T2-weighted 
(repetition time, 3,000 milliseconds; echo time, 120 milliseconds) and T1-weighted 
(repetition time, 400 milliseconds; echo time, 8 milliseconds) sagittal and transverse images. 
Slice thickness for sagittal and transverse images were 1.75 mm and 2.5 mm, respectively, 
with an interslice gap of 0.3 mm in both planes.  Myelographic studies were assessed for 
location and number of compressive IVDPs. Magnetic resonance imaging studies were 
assessed for the location and number of compressive IVDPs, the presence of 
intramedullary/intraparenchymal signal intensity (ISI) changes and the degree of spinal cord 
compression.  For the purpose of this study, a compressive IVDP was defined as an IVDP 
that caused distortion or deviation of the spinal cord.  ISI changes were defined as focal 
intraparenchymal areas that had a different intensity (hyper or hypointense) compared to the 
surrounding normal spinal cord parenchyma.  To evaluate the degree of spinal cord 
compression, the remaining spinal cord area was calculated at the site of the most pronounced 
compression. Measurements were made on T2-weighted images in the transverse plane.  The 
remaining spinal cord area was defined as the cross sectional area of the compressed spinal 
cord segment divided by the cross sectional area at the adjacent, non-compressed spinal cord 
segment.22 In dogs with multiple sites of spinal cord compression, the remaining spinal cord 
area was determined at the site where ISI changes were present or, if no ISI changes were 
present, at the site with subjectively the highest degree of spinal cord compression. All 
imaging studies were evaluated and all measurements performed by a board-certified 
neurologist unaware of the clinical presentation, type of treatment and outcome of the 
individual dog. Image analysis was performed with Osirix software.c 
Owners were informed of the diagnosis of thoracolumbar IVDP and consulted with a board 
certified veterinary neurologist or resident in a veterinary neurology training program 
regarding available treatment options. The final decision to pursue medical or surgical 
management was made by the owner(s) of each dog.  Medical treatment consisted of 
restricted exercise, combined with analgesic medication if indicated.  Surgical treatment 
consisted of a hemilaminectomy with anulectomy or with a partial discectomy. For the 
purposes of this study, dogs medically treated at our referral veterinary hospital but that 
subsequently received surgical treatment, due to inadequate response to medical treatment, 
were included in both treatment groups with regard to respective signalment and clinical 
signs.  
 
Follow up data was obtained only from dogs receiving medical treatment. Surgically 
managed dogs were not evaluated.  Data was obtained from medical records of re-
examination visits at the Royal Veterinary College 4 to 6 weeks after the diagnosis of 
thoracolumbar IVDP was made.  Local ethics and welfare committee guidelines stated that 
the owners of deceased dogs could not be contacted, and as all dogs had died by the time of 
evaluation, long term follow up data was obtained via review of the medical records of the 
referring veterinarians. Data collection included the date and cause of death, as well as the 
last documented clinical and neurological status.  Successful management was defined as 
sustained improvement or stabilization of mild clinical signs, with no subsequent 
neurological deterioration. More specifically, dogs had to be independently ambulatory, 
urinary and fecal continent, and, according to the referring veterinary surgeons, not 
displaying obvious signs of spinal hyperesthesia. For the purpose of this study, dogs that 
subsequently underwent surgery because of progression of their clinical signs after medical 
management were considered to have an unsuccessful outcome. 
Statistical analysis—Data analysis was performed with the aid of a standard statistical 
software package.d Data was assessed for normal distribution using the Shapiro-Wilk test for 
normality.  An independent samples T-test was used to compare age, body weight and degree 
of spinal cord compression between medically and surgically treated dogs.  A Mann-Whitney 
U test was used to compare duration of clinical signs between medically and surgically 
treated dogs.  A Fisher exact test was used to compare all other assessed variables. Values of 
p < 0.05 were considered significant.  
 
Results 
 
Eighty-four dogs were included in the study, of which 31 received medical treatment and 53 
received surgical treatment.   
 
Medical treatment group  
 
The mean age of medically treated dogs was 9 years (SD ±2.3) and the mean body weight was 
28.1kg (SD ±9.6) (Table 1).  Fourteen dogs were female, and 17 were male. Breeds represented 
were the Staffordshire bull terrier (9), German Shepherd dog (8), Labrador retriever (2), Dalmatian 
(2), 8 breeds were represented by 1 dog each (Standard poodle, Bassett hound, Bull mastiff, English 
springer spaniel, Golden retriever, Border collie, Airedale and English Bull terrier), and 2 dogs were 
cross breeds.  The median duration of clinical signs was 30 days (IQR 177).   Presenting clinical 
signs included paraparesis (54.8%), proprioceptive ataxia of the pelvic limbs (46.7%), difficulty 
jumping (43.3%), pain (30%) and toileting in the house (13.3%). Neurological deficits were 
detected in 26 dogs (83.9%), including proprioceptive ataxia of the pelvic limbs (20), paraparesis 
(19), postural reaction deficits (25), and increased (7) or decreased (4) spinal reflexes in the pelvic 
limbs.  All dogs were ambulatory on hospital admission. Affected dogs had neurological grades 4 
(27) or 5 (4). 16 dogs (51.6%) had received medical treatment prior to referral.  Treatment consisted 
of NSAIDs in 8 dogs, tramadol hydrochloride in 3 dogs, gabapentin in 2 dogs, a combination of 
NSAIDs and gabapentin in 2 dogs, and oral prednisolone in 1 dog.  This resulted in an improved 
clinical status in 10 (62.5%) of the 16 dogs prior to initial evaluation at our referral hospital. 
Twenty-two (71%) dogs had a concurrent disease at the time of presentation.  Fifteen dogs (48.3%) 
had non-orthopaedic concurrent disease, including chronic skin disease (2), hyperadrenocorticism 
(2), hepatopathy (2), chronic kidney disease (2), pancreatitis (1), chronic peripheral vestibular 
disease (1), epilepsy (1), chronic respiratory disease (1), soft tissue sarcoma (1), inflammatory 
bowel disease (1) and hypothyroidism (1).  Eighteen (58.1%) dogs had concurrent orthopaedic 
conditions including multiple joint osteoarthritis (8), elbow osteoarthritis (3), stifle osteoarthritis (3), 
partial cruciate ligament rupture (2) and hip osteoarthritis (2). Eleven dogs had a concurrent 
orthopaedic and non-orthopaedic condition. All 31 dogs underwent MRI of the thoracolumbar 
spinal cord. Nine dogs (29%) had a single IVDP identified on MRI, and 22 dogs (71%) had multiple 
IVDPs (12 dogs had 2 sites of IVDP, 8 had 3 sites and 2 had 4 sites). Intramedullary signal intensity 
changes at the site of the compressive IVDP(s) were detected in 15 dogs (48.4%). The mean 
remaining spinal cord area was 67.2% (SD ±18.1) at the site of most severe compression. 
 
Surgical treatment group 
 
53 dogs received surgical treatment, which consisted of a hemilaminectomy with anulectomy (29) 
or a hemilaminectomy combined with a partial discectomy (24).  Breeds represented were the 
German Shepherd dog (22), Staffordshire bull terrier (10), Basset hound (5), Labrador retriever (3), 
Dalmatian (3), Golden retriever (2), with 4 breeds represented by 1 dog each (Bull mastiff, 
Rottweiler, English pointer, Bernese Mountain Dog) and 4 cross breeds. The mean age was 8.8yrs 
(SD ±2.1) and the mean body weight was 32.9kg (SD ±10.8) (Table 1). Thirteen dogs were female, 
and 40 were male. The median duration of clinical signs was 30 days (IQR 158).  Presenting 
complaints included paraparesis (83%), proprioceptive ataxia of the pelvic limbs (49.1%), difficulty 
jumping (9.4%), pain (22.6%) and toileting in the house (5.7%). Sixteen dogs (30.2%) had received 
medical treatment prior to referral. Treatment consisted of NSAIDs in 7 dogs, tramadol 
hydrochloride in 3 dogs, gabapentin in 1 dog, NSAID in combination with gabapentin in 1 dog, 
NSAID in combination with tramadol hydrochloride in 2 dogs and prednisolone in 2 dogs.  This 
resulted in an improved clinical status in 2 (12.5%) of the 16 dogs prior to evaluation at our referral 
hospital. Neurological deficits were detected in all 53 dogs (100%), including proprioceptive ataxia 
of the pelvic limbs (38), paraparesis (36), paraplegia (4), postural reaction deficits (40), increased 
(14) or decreased  (6) spinal reflexes in the pelvic limbs, and absent nociception in the pelvic limbs 
(1). Seventeen dogs (32.1%) were non-ambulatory at hospital admission. Thirty-six dogs were 
grade 4, 13 were grade 3, 3 were grade 2, and 1 was grade 0. 
Twelve (22.6%) dogs had concurrent disease at the time of presentation.  Five dogs (9.4%) had non-
orthopaedic concurrent disease, including a heart murmur (1), anal furunculosis (1), urinary tract 
infection (1), laryngeal paralysis (1) and chronic diarrhea (1). Seven (13.2%) dogs had concurrent 
orthopaedic conditions, including osteoarthritis of multiple joints (4), hip osteoarthritis (1) elbow 
osteoarthritis (1) and partial cruciate ligament rupture (1). Five dogs underwent a myelogram, and 
the remaining 48 underwent MRI of the thoracolumbar spinal cord.  Nineteen dogs (35.8%) had a 
single IVDP, and 34 dogs (64.2%) had multiple IVDPs (19 dogs had 2 sites of IVDP, 14 had 3 sites 
and 1 had 4 sites).  Intramedullary signal intensities at the site of the compressive IVDP(s) were 
detected in 17 dogs (32.1%). The mean remaining spinal cord area was 54.8% (SD ±21.3), at the 
site of most severe compression.  
 
Comparison of clinical presentation between medically and surgically treated dogs 
Compared with medically treated dogs, more surgically treated dogs had neurological deficits on 
presentation (p=0.015), were non-ambulatory at the time of hospital admission (p<0.0001), had a 
lower neurological grade (p=0.001) and had undergone unsuccessful medical treatment prior to 
referral (p=0.009) (Table 1). More medically treated dogs were found to have concurrent disease 
(p<0.0001) at the time of presentation, as well as a greater remaining spinal cord area (p=0.0.14), 
implying less severe spinal cord compression.  The age, body weight, duration of clinical signs, 
presence of single or multiple sites of IVDP and the presence of ISI changes were not significantly 
different between treatment groups. 
 
Treatment and outcome for medically treated dogs: 
 
Medically treated dogs underwent 2 to 6 weeks (mean 4.3 weeks, median 4) of restricted exercise.  
Additionally, NSAIDs were administered in 14 dogs, gabapentin in 5, tramadol hydrochloride in 2, 
and gabapentin in combination with a NSAID in 3. Twenty-four of the 31 dogs were re-examined 4-
6 weeks after a diagnosis of IVDP was made.  Of these, 15 (62.5%) demonstrated a clinical 
improvement compared with their initial presentation, 6 (25%) remained stable and 3 (12.5%) had 
deteriorated. Four dogs (16.7%) were found to be neurologically normal on re-examination, while 
the remaining 20 (83.3%) showed neurological deficits (all with a neurological grade of 4).  
 
All 31 dogs had died at the time of data collection and, due to ethical and welfare committee 
approval of the study, long-term follow up data was obtained from the referring veterinarians.  
Interval from diagnosis to collection of follow up information ranged from 24 to 118 months 
(mean: 67.3 months, median: 67.7).  Sufficient long term outcome data was available for 27 
of the 31 dogs; 11 (40.7%) improved with treatment, 7 (25.9%) remained stable, and 9 
(33.3%) deteriorated after starting medical management of thoracolumbar IVDP (Figure 1).  
Of these 9, 3 were euthanized because of their IVDP 5, 28 and 35 days after hospital 
discharge. The remaining 6 dogs (66.7%) subsequently underwent surgical treatment due to 
their unsatisfactory response to medical management.  The interval from diagnosis to surgical 
treatment ranged from 6 to 120 days (mean and median of 59.5 days).  Surgery in these 6 
dogs was without complications, and all dogs showed a clinical improvement 
postoperatively, although 3 showed persistent ataxia and paresis of the pelvic limbs 
(neurological grade 4).   
Of the 11 dogs that improved with medical treatment, 5 then remained stable (4 were reported to be 
neurologically normal and 1 showed mild paraparesis) and were finally euthanized for unrelated 
reasons (median survival time of 563 days), 4 remained stable for a median of 165 days before 
showing neurological deterioration leading to euthanasia and the 2 remaining dogs remained stable 
for 310 and 365 days before acute neurological deterioration leading to euthanasia. Further 
diagnostic investigations were not undertaken prior to euthanasia in any of the dogs.  
 
Of the 7 dogs that remained stable with medical treatment, 3 were ultimately euthanized for 
unrelated reasons with a median survival time of 363 days (all 3 showed mild paraparesis and 
proprioceptive ataxia, neurological grade 4), 3 remained stable before then showing gradual 
neurological deterioration leading to euthanasia (median survival time of 120 days), and the 
remaining dog remained stable for 84 days before acute neurological deterioration and euthanasia. 
Further diagnostic investigations were not undertaken prior to euthanasia in any of these dogs.  
 
The median survival time for all dogs receiving medical treatment was 330 days.  
Overall, 8 of 27 (29.6%) dogs for which long term follow up information was available were 
considered to have a successful outcome, defined as sustained clinical improvement with no 
recurrence of neurological deficits, after medical treatment for thoracolumbar IVDP.  
 
Discussion 
 This study compared the clinical presentation of dogs receiving medical or surgical treatment 
for thoracolumbar IVDP (Hansen type II intervertebral disc disease), and assessed the 
outcome following medical treatment. Compared with medically treated dogs, dogs treated 
surgically for thoracolumbar IVDP were significantly more likely to have neurologic deficits 
at presentation, to be non-ambulatory, and to have received unsuccessful medical treatment 
prior to referral. In agreement with previous findings14,23,24, the results of this study indicate 
that more severely affected dogs, as well as those that fail initial medical management, were 
generally treated surgically, while dogs with a less severe clinical phenotype were typically 
treated medically. As the success of treatment is likely to be influenced by the severity of the 
underlying disease, the differences in clinical presentation found in this study unfortunately 
prevent a direct comparison of the outcome between medically and surgically treated dogs. 
Outcome after surgical treatment was therefore not evaluated. 
Concurrent disease at the time of presentation was more common in the medically treated 
group.  Such concurrent disease may influence clinical decision-making in terms of the 
anticipated perioperative morbidity associated with such conditions, as well as their potential 
impact on long-term quality of life and survival time.    
Only 29.6% of dogs were considered to have a successful long-term outcome after medical 
management for thoracolumbar IVDP and 13 of the 27 dogs for which long-term follow-up 
information was available were ultimately euthanized for progression or recurrence of their 
spinal disease. These results are similar to a previous study evaluating medical management 
of large breed dogs with anulus fibrosus protrusions,4 but are lower than those reported for 
suspected cervical and lumbar disc herniations12,24, as well as for disc-associated cervical 
spondylomyelopathy and degenerative lumbosacral stenosis.22,23  It is therefore possible that 
thoracolumbar IVDP may be associated with a less favorable prognosis than other disc-
associated degenerative spinal disorders.   
Eighteen of 27 of dogs showed an initial good response to medical treatment with 
improvement or stabilization of mild clinical signs for several months.  However, this period 
was followed by neurological deterioration in 10 of the18 dogs, resulting in euthanasia of all 
10. Unfortunately, none of these dogs underwent repeat diagnostic investigations and hence 
the cause of the deterioration is unknown and potentially multifactorial.  Thoracolumbar 
IVDP is often associated with multiple sites of spinal cord compression and hence 
deterioration of neurological status could have been caused by development or progression of 
compressive IVDPs at adjacent intervertebral disc spaces. This hypothesis is similar to the 
development of adjacent segment disease, which has been reported after lumbar fusion in 
human medicine25,26 and with medical management of dogs with disc-associated cervical 
spondylomyelopathy.22 Alternatively, deterioration may also be caused by progressive 
herniation of the initially affected intervertebral disc. Finally, we cannot exclude that an 
unrelated spinal disease may have caused the neurological deterioration. Further studies to 
evaluate the pathogenesis of this clinical deterioration may reveal risk factors for disease 
recurrence and hence guide clinical decision-making.  
The poor response to medical management found in this study suggests that further studies of 
outcome after surgical decompression and of alternative medical treatment options for dogs 
with chronic spinal cord compression would be worthwhile.  In a recent study the potassium 
channel antagonists 4-aminopyridine and the T-butyl carbamate derivative of 4-
aminopyridine were found to improve hind limb function in chronically non-ambulatory 
dogs.  Their use in thoracolumbar IVDP may therefore prove beneficial.27  Furthermore, 
physiotherapy and hydrotherapy have become increasing available in veterinary medicine, 
but no studies have yet objectively evaluated their use in dogs with thoracolumbar IVDP.  
All dogs in the present study underwent a period of restricted exercise.  However, there is 
growing evidence in both research models and in human clinical trials to suggest that 
controlled exercise can be beneficial in controlling pain, minimizing degenerative changes 
and potentially promoting repair within the intervertebral disc28-33. Therefore, restricted 
exercise may be inappropriate, and the use of regular controlled exercise regimen should be 
investigated. Furthermore, physiotherapy and hydrotherapy have become increasingly 
available in veterinary medicine, but no studies have yet objectively evaluated their use in 
dogs with thoracolumbar IVDP.   
Of the nine dogs that deteriorated despite medical treatment, six underwent subsequent 
surgical decompression and showed a clinical improvement post-operatively, suggesting that 
prior medical treatment does not exclude the possibility of a positive response to surgery. 
Three dogs failed to regain a normal neurological status post-operatively and so it is possible 
that a higher degree of clinical improvement may have been seen if surgical decompression 
had not been delayed. Further studies to evaluate the results of surgical treatment after 
prolonged medical management and more gradual neurological deterioration would be 
worthwhile. 
The present study was limited by its retrospective nature, and the associated variability in 
evaluation of objective clinical outcome measures.  Although an accepted neurological 
grading system was used, the majority of dogs were ambulatory at presentation and were 
therefore assigned a similar neurological grade, which likely limited recognition of more 
subtle differences in severity of clinical signs. It is therefore important to realize that most 
accepted and validated grading systems for dogs with spinal disease are designed for dogs 
with acute thoracolumbar spinal disorders, such as IVDE21,26,34, with few studies focusing on 
grading ambulatory dogs or dogs with chronic thoracolumbar spinal disease.35  Finally, the 
study population consisted of a referral hospital’s case load which may represent cases with a 
more severe clinical phenotype and/or highly motivated owners, and may not accurately 
represent the general dog population.   
Despite the limitations of the present study the data obtained revealed that medical 
management of thoracolumbar IVDP is typically reserved for ambulatory dogs that have 
shown a positive response to prior medical treatment and have less severe spinal cord 
compression. Furthermore, these dogs tend to have concurrent disease at the time of 
presentation. Medical treatment of thoracolumbar IVDP was associated with a fair to guarded 
prognosis with a success rate of 29.6% (8/27) and a median survival time of 330 days. 
Further studies are needed to prospectively compare medical and surgical treatment of 
thoracolumbar IVDP, to determine prognostic indicators of treatment response and disease 
recurrence, as well as to investigate new treatment modalities for the management of chronic 
spinal cord compression.  
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Figure legends: 
 
Table 1: Signalment, clinical signs and imaging findings of dogs treated medically and surgically for 
IVDP at a small animal referral hospital. IVDP: intervertebral disk protrusion, yrs: years, ISI: 
intramedullary signal intensity, SD: standard deviation. 
Figure 1: Schematic depiction of the long term outcome for dogs receiving medical treatment for 
thoracolumbar IVDP.  (MST: median survival time). 
  
Table 1: 
Variable Medical (n=31) Surgical (n=53) p value 
Age (yrs) 9 (SD±2.3) 
 
8.8 (SD±2.1) 
 
0.254 
 
Male 17 40 0.052 
Female 14 13 0.052 
Body weight 28.1kg (SD±9.6) 32.9kg (SD±10.8) 
 
0.168 
Duration of clinical signs (days) 30 30 0.985 
Neurological deficits 26 (84%) 53 (100%) 0.015 
Ambulatory at hospital  
admission 
31 (100%) 36 (68%) <0.000 
Medical treatment prior to 
referral 
16 (52%) 16 (30%) 0.033 
Positive response to medical 
treatment 
10 (63%) 2 (13%) 0.009 
Concurrent medical condition 
Orthopaedic 
Non-orthopaedic 
22 (71%) 
18 
15 
12 (22.6%) 
7 
5 
<0.000 
0.007 
<0.000 
Single IVDP 
Multiple IVDP 
9 (29%) 
22 
19 (36%) 
34 
0.385 
0.385 
ISI changes 15 (48%)  17 (32%) 0.168 
Remaining spinal  
cord area (%) 
67.2 (SD ± 18.1) 54.8 (SD ± 21.3) 0.014 
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